Red cell aplasia
Showing 1 - 25 of >10,000
Diamond Blackfan Anemia, Pure Red Cell Aplasia Trial in Boston, Manhasset (Trifluoperazine)
Terminated
- Diamond Blackfan Anemia
- Pure Red Cell Aplasia
-
Boston, Massachusetts
- +1 more
Nov 18, 2022
Immunological Pure Red Cell Aplasia Trial (Isatuximab)
Not yet recruiting
- Immunological Pure Red Cell Aplasia
- (no location specified)
Sep 26, 2022
Pure Red Cell Aplasia Trial in Beijing (Sirolimus)
Completed
- Pure Red Cell Aplasia
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 1, 2021
Aplastic Anemia, Pure Red Cell Aplasia, Diamond Blackfan Anemia Trial run by the NHLBI (Daclizumab)
Terminated
- Aplastic Anemia
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +36 more
- Cyclophosphamide
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 23, 2023
Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder Trial in Calgary (Alemtuzumab, Total Body
Recruiting
- Sickle Cell Disease
- +3 more
- Alemtuzumab
- +2 more
-
Calgary, Alberta, CanadaAlberta Children's Hospital
May 25, 2021
Acquired Pure Red Cell Aplasia Trial in Tianjin (bortezomib/dexamethasone)
Recruiting
- Acquired Pure Red Cell Aplasia
-
Tianjin, ChinaRegenerative Medicine Center
Sep 13, 2020
Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol
Recruiting
- Adenine Phosphoribosyltransferase Deficiency
- +83 more
-
Bristol, South West, United KingdomZoe Plummer
Sep 26, 2023
Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United
Recruiting
- Bone Marrow Failure Syndrome
- +6 more
- Treosulfan
- +7 more
-
Los Angeles, California
- +23 more
Aug 15, 2022
Autoimmune Hemolytic Anemia, Pure Red Cell Aplasia, Evans Syndrome Trial in Beijing (Tacrolimus)
Unknown status
- Autoimmune Hemolytic Anemia
- +2 more
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Dec 1, 2019
Anemia, Age Problem, Ultrasonography Trial in Nîmes (transthoracic echocardiography)
Not yet recruiting
- Anemia
- +2 more
- transthoracic echocardiography
-
Nîmes, Gard, FranceCHU de Nîmes
Sep 25, 2023
Pancreatic Diseases Trial in Shanghai (Red cell lysis buffer (RCLB) application, Conventional processing)
Not yet recruiting
- Pancreatic Diseases
- Red cell lysis buffer (RCLB) application
- Conventional processing
-
Shanghai, Shanghai, ChinaChanghai Hospital
Jul 12, 2023
Blood Loss Anemia, Extracorporeal Membrane Oxygenation Complication Trial (Red Blood Cell Transfusion)
Not yet recruiting
- Blood Loss Anemia
- Extracorporeal Membrane Oxygenation Complication
- Red Blood Cell Transfusion
- (no location specified)
Apr 3, 2023
Width and Lactate Albumin Ratio as Prognostic Markers for
Not yet recruiting
- Morality
- +2 more
- Red cell distribution width
- lactate albumin ratio measurement
-
Tanta, Elgharbia, EgyptTanta University Hospitals
Jun 18, 2023
Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution
Recruiting
- Polycythemia Vera
-
Sohag, EgyptFaculty of Medicine
Aug 12, 2023
Platelet and Red Blood Cell Volume Indices as Inflammatory
Recruiting
- Ankylosing Spondylitis
- CBC
-
Sohag, EgyptSohag university Hospital
Aug 10, 2023
Study of a Deformability Parameter of Red Blood Cell
Not yet recruiting
- Drepanocytosis
- basal blood collection
- +2 more
- (no location specified)
May 10, 2023
Polycythemia Trial (CO-Rebreathing technique at diagnosis of polycythemia)
Completed
- Polycythemia
- CO-Rebreathing technique at diagnosis of polycythemia
-
Amiens, Picardie, FranceCHU Amiens Picardie
Jan 17, 2023
B-cell Acute Lymphoblastic Leukemia Trial in New York (Tisagenlecleucel)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Tisagenlecleucel
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 13, 2022
Red Blood Cell Transfusion, Oxygen Consumption Trial in Izmir (No intervention group.)
Not yet recruiting
- Red Blood Cell Transfusion
- Oxygen Consumption
- No intervention group.
-
Izmir, TurkeyIzmir Katip Celebi University Ataturk Training and Research Hosp
Mar 22, 2023
Red Blood Cell Disorder, Oxidative Stress, Iron Metabolism Disorders Trial in Poznan (THYROX (Atlantic krill oil)., Placebo)
Recruiting
- Red Blood Cell Disorder
- +2 more
- THYROX (Atlantic krill oil).
- Placebo
-
Poznań, PolandPoznań University of Physical Education
Nov 21, 2023
Cancer, Solid Tumor, Hematologic Malignancy Trial in Hangzhou (engineered red blood cell WTX212)
Recruiting
- Cancer
- +2 more
- engineered red blood cell WTX212
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People'S Hospital
Jan 21, 2023
Sickle Cell Disease Without Crisis Trial in Chapel Hill (G6PD Deficient Red Blood Cell Transfusion, Non-G6PD deficient Red Blood
Recruiting
- Sickle Cell Disease Without Crisis
- G6PD Deficient Red Blood Cell Transfusion
- Non-G6PD deficient Red Blood Cell Transfusion
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Aug 15, 2022
Resectable Pancreatic Carcinoma Trial (biological, procedure, other)
Not yet recruiting
- Resectable Pancreatic Carcinoma
- Arm I Packed Red Blood Cell Transfusion (Hgb < 7 g/dL)
- +6 more
- (no location specified)
Apr 24, 2023
Individualized Transfusion Strategy, Red Blood Cell, Perioperative Pediatric Patient Trial (clinical condition score)
Withdrawn
- Individualized Transfusion Strategy
- +3 more
- clinical condition score
- (no location specified)
Aug 4, 2022